Tickers: XCNQ:APP, PINX:FUAPF
Tags: Medicinal Marijuana, Mining, Technology
In September 2017, GCAC intends to commence trials on a proprietary AI regulatory monitoring platform to manage international ISO standards for medical cannabis. The data collected from this technology is anticipated to augment the existing data pool used within GCAC's Citizen Green App suite and proprietary 'Pain to Strain' database.
AI compliance technology proposes to help deliver a near bullet proof auditing system for regulatory compliance across global jurisdictions, and may have immediate application to 'Schedule 8' medical cannabis regulation in countries such as Australia.
Blockchain is a disruptive, secure, digital "distributed ledger" that is being heralded as a significant innovation that could have far reaching implications in health and financial industries. The technology may be used to collect data from and improve medical cannabis supply chains.
These cutting-edge technologies coupled with Citizens Green's "Pain to Strain' database (built from over 10 years of field research tracking medicinal cannabis users seeking therapeutic remedies for multiple conditions including cancer and epilepsy), have the potential to generate significant improvements on data insights for ongoing clinical trials in the medical cannabis arena.
"This is an exciting new frontier. GCAC eagerly anticipates exploring AI along with the application of Blockchain technology fed by dynamic social media to provide the basis for curating authoritative data for medical practitioners, researchers, providers and growers," says Jason Webb, Managing Director of GCAC, Australia.
GCAC's business is focused on 'big data', which will be aggregated through various technologies enabling users, patients, doctors, pharmacists, providers and practitioners to more easily identify key strains of cannabis that have the greatest benefit to targeted ailments for personal well-being.
States GCAC CEO, Brad Moore, "Our innovative approach to technology in the medical cannabis space alongside the rich data experience derived from our Citizen Green Apps will build the foundational blocks for understanding and participating in the growing world of medical cannabis."
About Global Cannabis Applications Corp.
To schedule an interview, please contact:
Bradley Moore
Chief Executive Officer
Telephone: 514-561-9091
Email: [email protected]
For more information, please contact:
Corporate Communications
Telephone: 1.855.269.9554
Email: [email protected]
www.cannappscorp.com
Forward-Looking Information
The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy and accuracy of this information.
Copyright (c) 2017 TheNewswire - All rights reserved.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
